Louis Aledort, MD, Hematology, New York, NY, Mount Sinai School of Medical

LouisMAledortMD

Hematology New York, NY

Professor of Medicine, Mount Sinai School of Medicine

Dr. Aledort is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Aledort's full profile

Already have an account?

  • Office

    1140 madison ave
    Mount Sinai Hospital Ruttenberg Treatment Center Hem
    New York, NY 10029
    Phone(212) 860-0205
    Fax(212) 987-3326
  • Is this information wrong?

Education & Training

  • University of Rochester
    University of RochesterRESIDENCY
  • University of Virginia
    University of VirginiaRESIDENCY
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2016 - 2018
  • NY State Medical License
    NY State Medical License 1963 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Research Paper Application of Phospho-CyTOF to Characterize Immune Activation in Patients with Sickle Cell Disease in an Ex Vivo Model of Thrombosis  
    Louis Aledort, MD, ScienceDirect

Press Mentions

  • Hemophilia Drug Hemlibra: Adverse Events Reports and Patient Deaths Raise Some Concerns
    Hemophilia Drug Hemlibra: Adverse Events Reports and Patient Deaths Raise Some ConcernsDecember 10, 2019

Grant Support

  • Safety And Clinical Efficacy Of Recombinant DNA Derived Factor VIIINational Center For Research Resources1993–1994
  • Intranasal Ddavp Spray In Mild Hemophilia And Von Willebrand'S DiseaseNational Center For Research Resources1992
  • Safety &Clinical Efficacy Of Recombinant DNA Derived Factor VIIINational Center For Research Resources1990–1992
  • Recovery And Half-Life Studies Of Factor VII, VIII And IXNational Center For Research Resources1990–1991
  • IVIG In Treatment Of Autoimmune &Alloimmune Antibodies To Coagulation FactorsNational Center For Research Resources1990–1991
  • Immunoabsorption For Inhibitors To Factors VIII And IXNational Center For Research Resources1990
  • Study Of IV Gamma Globulin For Treatment Of Autoimmune/Alloimmune AntibodiesNational Center For Research Resources1989
  • Immunoabsorption For Inhibitors To Factors VIII And VNational Center For Research Resources1988–1989

Hospital Affiliations